Skip to main content
Caplight Logo









Anagenex

Anagenex

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://anagenex.com/

Last Round

Series A

Jun 8, 2022

Total Funding Raised

$44.4M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Anagenex is a biotechnology company that provides a drug discovery platform combining ultra-high-throughput biochemistry, DNA-encoded library technology, and machine learning to identify and optimize small molecule therapeutics for challenging medical targets.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Infrastructure

Keywords

small molecule drug discoverydirected evolutiondrug discovery platformundruggable targetsDNA-encoded librariesaffinity-selected mass spectrometryAI drug discoverybiotech R&Din silico drug discoverylead optimizationpharma partnershipAI-native biotechcomputational biologyASMS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Anagenex Comparables

Compare Anagenex with similar companies based on industry and business-model similarity.

Anagenex comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Terray Therapeutics
81%
Leash Bio
81%
Orogen Therapeutics
80%

Anagenex Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJun 8, 2022

Anagenex Investors

Notable investors and investment history

Anagenex investors
InvestorRounds
Khosla VenturesSeed, Series A
Air Street CapitalSeed, Series A
Lux CapitalSeries A, Seed
Catalio Capital ManagementSeries A
Obvious VenturesSeed, Series A
Menlo VenturesSeed, Series A
Alloy FundSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors grew 146% MoM, reaching 39.6K.

Anagenex Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Anagenex Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Anagenex's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range5
Year Founded2019
Last FundingJun 8, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?